Image

    Is 3α, 17β-Androstanediol-Glucuronide a Diagnostic Marker in Women with Androgenic Manifestations?

    January 1992 in “ Gynecological Endocrinology
    Cornelia Vogt, J. S. E. Dericks-Tan, H. Kühl, H.‐D. Taubert
    Studysummary This study concluded that serum Adiol-G levels generally parallel testosterone levels and, therefore, do not effectively serve as a marker of peripheral androgen excess in women with androgenic symptoms.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tandfonline.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Clinical Usefulness of Plasma Androstanediol Glucuronide Measurements in Women with Idiopathic Hirsutism ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 1987
    2. Treatment of Hirsutism with 5α-Reductase Inhibitors Clinics in endocrinology and metabolism · 1986
    3. 3 Alpha, 17 Beta-Androstanediol Glucuronide in Plasma: A Marker of Androgen Action in Idiopathic Hirsutism ˜The œJournal of clinical investigation/˜The œjournal of clinical investigation · 1982

    Related research 1

    1. Metabolism of Androgens by Isolated Human Beard Hair Follicles Steroids · 1971